과제정보
This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2013R1A1A4A01013202) and a grant from Chungnam National University (2014).
참고문헌
- Schoenhaut, D. S., A. O. Chua, A. G. Wolitzky, P. M. Quinn, C. M. Dwyer, W. McComas, P. C. Familletti, M. K. Gately, and U. Gubler. 1992. Cloning and expression of murine IL-12. J. Immunol. 148: 3433-3440. https://doi.org/10.4049/jimmunol.148.11.3433
- Trinchieri, G. 1994. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84: 4008-4027. https://doi.org/10.1182/blood.V84.12.4008.bloodjournal84124008
- Hsieh, C. S., S. E. Macatonia, C. S. Tripp, S. F. Wolf, A. O'Garra, and K. M. Murphy. 1993. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260: 547-549. https://doi.org/10.1126/science.8097338
- Gately, M. K., R. R. Warrier, S. Honasoge, D. M. Carvajal, D. A. Faherty, S. E. Connaughton, T. D. Anderson, U. Sarmiento, B. R. Hubbard, and M. Murphy. 1994. Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-gamma in vivo. Int. Immunol. 6: 157-167. https://doi.org/10.1093/intimm/6.1.157
- Hendrzak, J. A., and M. J. Brunda. 1996. Antitumor and antimetastatic activity of interleukin-12. Curr. Top. Microbiol. Immunol. 213 (Pt 3): 65-83. https://doi.org/10.1007/978-3-642-80071-9_5
- Nastala, C. L., H. D. Edington, T. G. McKinney, H. Tahara, M. A. Nalesnik, M. J. Brunda, M. K. Gately, S. F. Wolf, R. D. Schreiber, W. J. Storkus, and . 1994. Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production. J. Immunol. 153: 1697-1706. https://doi.org/10.4049/jimmunol.153.4.1697
- Brunda, M. J., L. Luistro, R. R. Warrier, R. B. Wright, B. R. Hubbard, M. Murphy, S. F. Wolf, and M. K. Gately. 1993. Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J. Exp. Med. 178: 1223-1230. https://doi.org/10.1084/jem.178.4.1223
- Leonard, J. P., M. L. Sherman, G. L. Fisher, L. J. Buchanan, G. Larsen, M. B. Atkins, J. A. Sosman, J. P. Dutcher, N. J. Vogelzang, and J. L. Ryan. 1997. Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production. Blood 90: 2541-2548.
- Atkins, M. B., M. J. Robertson, M. Gordon, M. T. Lotze, M. DeCoste, J. S. DuBois, J. Ritz, A. B. Sandler, H. D. Edington, P. D. Garzone, J. W. Mier, C. M. Canning, L. Battiato, H. Tahara, and M. L. Sherman. 1997. Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies. Clin. Cancer Res. 3: 409-417.
- Car, B. D., V. M. Eng, J. M. Lipman, and T. D. Anderson. 1999. The toxicology of interleukin-12: a review. Toxicol. Pathol. 27: 58-63. https://doi.org/10.1177/019262339902700112
- Mach, N., and G. Dranoff. 2000. Cytokine-secreting tumor cell vaccines. Curr. Opin. Immunol. 12: 571-575. https://doi.org/10.1016/S0952-7915(00)00144-8
- Chang, C. J., K. F. Tai, S. Roffler, and L. H. Hwang. 2004. The immunization site of cytokine-secreting tumor cell vaccines influences the trafficking of tumor-specific T lymphocytes and antitumor efficacy against regional tumors. J. Immunol. 173: 6025-6032. https://doi.org/10.4049/jimmunol.173.10.6025
- Ji, J., J. Li, L. M. Holmes, K. E. Burgin, X. Yu, T. E. Wagner, and Y. Wei. 2004. Synergistic anti-tumor effect of glycosylphosphatidylinositol-anchored IL-2 and IL-12. J. Gene Med. 6: 777-785. https://doi.org/10.1002/jgm.547
- Tahara, H., and M. T. Lotze. 1995. Antitumor effects of interleukin-12 (IL-12): applications for the immunotherapy and gene therapy of cancer. Gene Ther. 2: 96-106.
- Kim, Y. S., C. H. Sonn, S. G. Paik, and A. L. Bothwell. 2000. Tumor cells expressing membrane-bound form of IL-4 induce antitumor immunity. Gene Ther. 7: 837-843. https://doi.org/10.1038/sj.gt.3301175
- Chang, M. R., W. H. Lee, J. W. Choi, S. O. Park, S. G. Paik, and Y. S. Kim. 2005. Antitumor immunity induced by tumor cells engineered to express a membrane-bound form of IL-2. Exp. Mol. Med. 37: 240-249. https://doi.org/10.1038/emm.2005.32
- Lim, H. Y., H. Y. Ju, H. Y. Chung, and Y. S. Kim. 2010. Antitumor effects of a tumor cell vaccine expressing a membrane-bound form of the IL-12 p35 subunit. Cancer Biol. Ther. 10: 336-343. https://doi.org/10.4161/cbt.10.4.12310
- Lim, H., S. A. Do, S. M. Park, and Y. S. Kim. 2013. Tumor Cell Clone Expressing the Membrane-bound Form of IL-12p35 Subunit stimulates antitumor immune responses dominated by CD8(+) T Cells. Immune Netw. 13: 63-69. https://doi.org/10.4110/in.2013.13.2.63
- D'Andrea, A., M. Rengaraju, N. M. Valiante, J. Chehimi, M. Kubin, M. Aste, S. H. Chan, M. Kobayashi, D. Young, E. Nickbarg, and . 1992. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J. Exp. Med. 176: 1387-1398. https://doi.org/10.1084/jem.176.5.1387
- Podlaski, F. J., V. B. Nanduri, J. D. Hulmes, Y. C. Pan, W. Levin, W. Danho, R. Chizzonite, M. K. Gately, and A. S. Stern. 1992. Molecular characterization of interleukin 12. Arch. Biochem. Biophys. 294: 230-237. https://doi.org/10.1016/0003-9861(92)90162-P
- Pan, W. Y., C. H. Lo, C. C. Chen, P. Y. Wu, S. R. Roffler, S. K. Shyue, and M. H. Tao. 2012. Cancer immunotherapy using a membrane-bound interleukin-12 with B7-1 transmembrane and cytoplasmic domains. Mol. Ther. 20: 927-937. https://doi.org/10.1038/mt.2012.10
- Lode, H. N., T. Dreier, R. Xiang, N. M. Varki, A. S. Kang, and R. A. Reisfeld. 1998. Gene therapy with a single chain interleukin 12 fusion protein induces T cell-dependent protective immunity in a syngeneic model of murine neuroblastoma. Proc. Natl. Acad. Sci. U. S. A. 95: 2475-2480. https://doi.org/10.1073/pnas.95.5.2475
- Collison, L. W., C. J. Workman, T. T. Kuo, K. Boyd, Y. Wang, K. M. Vignali, R. Cross, D. Sehy, R. S. Blumberg, and D. A. Vignali. 2007. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450: 566-569. https://doi.org/10.1038/nature06306
- Wang, Z., J. Q. Liu, Z. Liu, R. Shen, G. Zhang, J. Xu, S. Basu, Y. Feng, and X. F. Bai. 2013. Tumor-derived IL-35 promotes tumor growth by enhancing myeloid cell accumulation and angiogenesis. J. Immunol. 190: 2415-2423. https://doi.org/10.4049/jimmunol.1202535